NEWSROOM
News & Stories
Newsroom
Press Releases
Agendia Announces Upcoming Presentation of New Breast Cancer Data on Molecular Subtyping
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, February 27, 2014โ A scientific poster and lunch symposium at the upcoming Miami Breast Cancer Conference will focus new attention on genomic testing and molecular subtyping to refine breast Read More
Published Study Validates Agendiaโs MammaPrint Test for Long-Term Prediction of Breast Cancer Outcome
Researchers Conclude Molecular Test Is Able to Differentiate High and Low Recurrence Risk up to 25 Years after Diagnosis, Further Validating NEJM Study IRVINE, CA and AMSTERDAM, THE NETHERLANDS, February 17,2014 โ A newly published Read More
Agendiaโs MammaPrint & BluePrint Tests for Breast Cancer Highlighted at Personalized Medicine Conference
Next-Generation Genomic Tests Determine Molecular Subtypes and Risk of Recurrence, Providing More Precise Prognosis and Treatment IRVINE, CA and AMSTERDAM, THE NETHERLANDS, January 30, 2014 โ Molecular subtyping provides a more precise prognosis and valuable Read More